Abstract
A ten-year study of Stage III breast carcinoma has been reviewed in detail. The single most dominant variable was axillary nodal involvement. Four hundred and thirty patients had nodal metastases, 58 patients did not. Four hundred and thirty patients with axillary nodal involvement had fiveand ten-year recurrence rates of 68 and 77%, while the survival rates were 41 and 21%, respectively. Life span was influenced by extent of nodal disease, being best for those with micrometastases only, and worse for those with four or more positive nodes. Skin edema, infiltration, or ulceration in the positive node group were grave signs. Muscle invasion or node matting, however, did not appear to influence length of life. Postoperative prophylactic therapy did not appear to affect survival rates. Radiation therapy alone did not influence either local recurrence or survival rates. Not enough time has elapsed to evaluate the results of postoperative chemotherapy. Patients who underwent oophorectomy and radiation therapy appeared to do better, but the number of patients was small. Of the 58 patients without nodal invasion, 82% were alive at five years and 75% were alive at 10 years. Grave signs did not influence the survival rate in this group. While the majority of patients with Stage III carcinoma had unfavorable variables, there were some patients who demonstrated a low recurrence rate and a long survival time. Aggressive treatment should be designed to save those patients who can be helped and to improve those patients whose life expectancy is limited. There is no place for timid initial treatment whether by operation or by irradiation. It must be given with intent to cure even though palliation is most often attained.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bruckman J. E., Harris J. R., Levene M. B., Chaffey J. T., Hellman S. Results of treating stage III carcinoma of the breast by primary radiation therapy. Cancer. 1979 Mar;43(3):985–993. doi: 10.1002/1097-0142(197903)43:3<985::aid-cncr2820430330>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
- Fisher B., Montague E., Redmond C., Barton B., Borland D., Fisher E. R., Deutsch M., Schwarz G., Margolese R., Donegan W. Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial. Cancer. 1977 Jun;39(6 Suppl):2827–2839. doi: 10.1002/1097-0142(197706)39:6<2827::aid-cncr2820390671>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
- Fracchia A. A., Murray D. R., Farrow J. H., Balachandra V. K. Comparison of prophylactic and therapeutic castration in breast carcinoma. Surg Gynecol Obstet. 1969 Aug;129(2):270–276. [PubMed] [Google Scholar]
- Haagensen C. D., Stout A. P. Carcinoma of the Breast. II-Criteria of Operability. Ann Surg. 1943 Dec;118(6):1032–1051. doi: 10.1097/00000658-194312000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KENNEDY B. J., MIELKE P. W., Jr, FORTUNY I. E. THERAPEUTIC CASTRATION VERSUS PROPHYLACTIC CASTRATION IN BREAST CANCER. Surg Gynecol Obstet. 1964 Mar;118:524–540. [PubMed] [Google Scholar]
- Patchefsky A. S., Shaber G. S., Schwartz G. F., Feig S. A., Nerlinger R. E. The pathology of breast cancer detected by mass population screening. Cancer. 1977 Oct;40(4):1659–1670. doi: 10.1002/1097-0142(197710)40:4<1659::aid-cncr2820400440>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
- Pearlman N. W., Guerra O., Fracchia A. A. Primary inoperable cancer of the breast. Surg Gynecol Obstet. 1976 Dec;143(6):909–913. [PubMed] [Google Scholar]
- Ravdin R. G., Lewison E. F., Slack N. H., Dao T. L., Gardner B., State D., Fisher B. Results of a clinical trial concerning the worth of prophylactic oophorectomy for breast carcinoma. Surg Gynecol Obstet. 1970 Dec;131(6):1055–1064. [PubMed] [Google Scholar]
- Rubens R. D., Armitage P., Winter P. J., Tong D., Hayward J. L. Prognosis in inoperable stage III carcinoma of the breast. Eur J Cancer. 1977 Aug;13(8):805–811. doi: 10.1016/0014-2964(77)90134-7. [DOI] [PubMed] [Google Scholar]
- Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer. 1977 Jun;39(6 Suppl):2772–2782. doi: 10.1002/1097-0142(197706)39:6<2772::aid-cncr2820390665>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
- Strax P. Evaluation of screening programs for the early diagnosis of breast cancer. Surg Clin North Am. 1978 Aug;58(4):667–679. doi: 10.1016/s0039-6109(16)41580-x. [DOI] [PubMed] [Google Scholar]